drugset
drugset / Trial / NCT04209699

A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers

NCT04209699 ↗

Phase 1 Completed 18 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelTreatment

Summary

The primary purpose of this study is to evaluate the effects of food and pH on the relative bioavailability (BA) of the tablet formulation of BMS-986165 in healthy volunteers

Timeline

Start
2019-12-27
Primary completion
2020-02-04
Completion
2020-02-11

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule — —
Background Famotidine Other / unclassified — —

Indications

No indication recorded.